Trexquant Investment LP Acquires 227,825 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Trexquant Investment LP raised its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 112.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 431,230 shares of the company’s stock after buying an additional 227,825 shares during the period. Trexquant Investment LP owned about 0.50% of Pediatrix Medical Group worth $5,658,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in MD. Vanguard Group Inc. lifted its position in Pediatrix Medical Group by 1.1% in the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company’s stock valued at $141,861,000 after acquiring an additional 113,976 shares in the last quarter. State Street Corp lifted its holdings in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares in the last quarter. Pacer Advisors Inc. purchased a new position in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $35,492,000. Boston Partners grew its holdings in Pediatrix Medical Group by 25.2% during the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock worth $25,922,000 after buying an additional 393,600 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in Pediatrix Medical Group by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock valued at $25,562,000 after acquiring an additional 11,045 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors and hedge funds.

Pediatrix Medical Group Stock Performance

Shares of MD stock opened at $13.46 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The firm has a market cap of $1.16 billion, a price-to-earnings ratio of -11.22, a P/E/G ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 52 week low of $6.62 and a 52 week high of $17.67. The firm’s 50-day simple moving average is $14.42 and its two-hundred day simple moving average is $13.77.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million for the quarter, compared to analysts’ expectations of $486.22 million. As a group, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have recently commented on MD. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Macquarie started coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective for the company. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Finally, UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.